Yu, JunShen, BoChu, Eagle S. H.Teoh, NarcissusCheung, Kin FWu, Chung WWang, ShiyanLam, Cleo N YFeng, HaiZhao, JunhongCheng, Alfred S LTo, Ka-FaiChan, Henry L. Y.Sung, Joseph J Y2015-12-100270-9139http://hdl.handle.net/1885/66115Although peroxisome proliferator-activated receptor gamma (PPARγ) agonist have been shown to inhibit hepatocellular carcinoma (HCC) development, the role of PPARγ in hepatocarcinogenesis remains unclear. We investigated the therapeutic efficacy of PPAR�Keywords: adenovirus vector; caspase 3; caspase 7; caspase 9; diethylnitrosamine; Fas antigen; growth differentiation factor 15; peroxisome proliferator activated receptor gamma; poly(adenosine diphosphate ribose); rosiglitazone; tumor necrosis factor alpha; allele201010.1002/hep.235502016-02-24